Login / Signup
Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma.
Enrico Schalk
Kathleen Jentsch-Ullrich
Published in:
Annals of hematology (2023)
Keyphrases
</>
diffuse large b cell lymphoma
chronic lymphocytic leukemia
community dwelling
hodgkin lymphoma